Catalyst Wire Dossier Catalyst Wire Dossier

Suzetrigine

Suzetrigine · Vertex Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Suzetrigine, covering 2024-07-19 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy [Phase 3]

See pricing